In New Jersey, over 30 plaintiffs have filed lawsuits against Novo Nordisk, the pharmaceutical company behind Ozempic and Wegovy, alleging that the drugs increased the risk of developing a condition called Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION). NAION is a condition that leads to insufficient blood flow to the optic nerves. When blood flow to […]
The post Another Ozempic Mass Tort Developing in New Jersey appeared first on Houston Personal Injury Lawyers.